Fuan Pharmaceutical Group Co (300194) — Long-term Investment Intensity

Latest as of December 2019: 12.2%

Fuan Pharmaceutical Group Co (300194) has a Long-term Investment Intensity of 12.2% as of December 2019. Long-term investments of CN¥579.84 Million represent 12.2% of total assets of CN¥4.74 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Fuan Pharmaceutical Group Co net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

12.2%
LT Investments / Total Assets

Long-term Investments

CN¥579.84 Million
CNY

Total Assets

CN¥4.74 Billion
CNY

Country

China
SHE

Fuan Pharmaceutical Group Co Long-term Investment Intensity (2016–2019)

This chart shows how Fuan Pharmaceutical Group Co's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 12.2%, reflecting long-term investments of CN¥579.84 Million against total assets of CN¥4.74 Billion CNY. Also explore balance sheet size of Fuan Pharmaceutical Group Co for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Fuan Pharmaceutical Group Co (2016–2019)

The table below presents the year-by-year Long-term Investment Intensity for Fuan Pharmaceutical Group Co from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Fuan Pharmaceutical Group Co stock valuation.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2019 12.2% CN¥579.84 Million CN¥4.74 Billion ▲ +0.7 pp
2018 11.5% CN¥494.04 Million CN¥4.29 Billion ▲ +1.2 pp
2017 10.3% CN¥483.90 Million CN¥4.69 Billion ▼ -0.7 pp
2016 11.0% CN¥482.50 Million CN¥4.40 Billion
pp = percentage points